Literature DB >> 2742830

Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds.

A H Merrill1, S Nimkar, D Menaldino, Y A Hannun, C Loomis, R M Bell, S R Tyagi, J D Lambeth, V L Stevens, R Hunter.   

Abstract

Sphingosine, sphinganine, and other long-chain (sphingoid) bases inhibit protein kinase C in vitro and block cellular responses to agonists that are thought to act via this enzyme. To gain further insight into the mechanism of this inhibition, a series of long-chain analogues differing in alkyl chain length (11-20 carbon atoms), stereochemistry, and headgroup were examined for (a) inhibition of protein kinase C activity in vitro, (b) the neutrophil respiratory burst in response to phorbol myristate acetate (PMA), (c) the PMA-induced differentiation of HL-60 cells, and (d) the growth of Chinese hamster ovary cells. In every instance, the effects were maximal with the 18-carbon homologues, which are the same length as the predominant naturally occurring long-chain base (sphingosine). The lower potency of the shorter chain homologues was partially due to decreased uptake by cells. Small differences were obtained with the four stereoisomers of sphingosine (i.e., D and L forms of erythro- and threo-sphingosine), with N-methyl derivatives of the different sphingosine homologues, and with simpler alkylamines (e.g., stearylamine). The potency of the different headgroup analogues may be affected by the degree of protonation at the assay pH. The pKa of sphingosine was measured to be 6.7; the pKa varied among the analogues. These findings establish that the major structural features required for inhibition of protein kinase C and cellular processes dependent on this enzyme are the presence of a free amino group and an aliphatic side chain and that other groups have more subtle effects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742830     DOI: 10.1021/bi00434a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  Protein kinase inhibitors block neurite outgrowth from explants of goldfish retina.

Authors:  A M Heacock; B W Agranoff
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

2.  Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells.

Authors:  W C Hung; H C Chang; L Y Chuang
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

3.  Involvement of protein kinase C in the presynaptic nicotinic modulation of [(3)H]-dopamine release from rat striatal synaptosomes..

Authors:  L Soliakov; S Wonnacott
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

4.  Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor Properties.

Authors:  Eric J Miller; Suzanne G Mays; Mark T Baillie; Randy B Howard; Deborah G Culver; Manohar Saindane; Sarah T Pruett; Jason J Holt; David S Menaldino; Taylor J Evers; G Prabhakar Reddy; Richard F Arrendale; Michael G Natchus; John A Petros; Dennis C Liotta
Journal:  ACS Med Chem Lett       Date:  2016-03-21       Impact factor: 4.345

5.  Fumonisin B1 alters sphingolipid metabolism and immune function in BALB/c mice: immunological responses to fumonisin B1.

Authors:  E A Martinova; A H Merrill
Journal:  Mycopathologia       Date:  1995-06       Impact factor: 2.574

6.  Sphingolipid analogues inhibit development of malaria parasites.

Authors:  Esmeralda V S Meyer; Jason J Holt; Kathryn R Girard; Mark T Ballie; Anatoliy S Bushnev; Stacey Lapp; David S Menaldino; Richard F Arrendale; G Prabhakar Reddy; Taylor J Evers; Randy B Howard; Deborah G Culver; Dennis C Liotta; Mary R Galinski; Michael G Natchus
Journal:  ACS Med Chem Lett       Date:  2011-12-06       Impact factor: 4.345

7.  Novel synthesis and biological evaluation of enigmols as therapeutic agents for treating prostate cancer.

Authors:  Ethel C Garnier-Amblard; Suzanne G Mays; Richard F Arrendale; Mark T Baillie; Anatoliy S Bushnev; Deborah G Culver; Taylor J Evers; Jason J Holt; Randy B Howard; Lanny S Liebeskind; David S Menaldino; Michael G Natchus; John A Petros; Harsha Ramaraju; G Prabhakar Reddy; Dennis C Liotta
Journal:  ACS Med Chem Lett       Date:  2011-03-25       Impact factor: 4.345

8.  Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism.

Authors:  T Hashizume; T Sato; T Fujii
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

9.  Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells.

Authors:  R Kothapalli; N Guthrie; A F Chambers; K K Carroll
Journal:  Lipids       Date:  1993-11       Impact factor: 1.880

10.  Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is promoted by sphingosine.

Authors:  H Wakita; Y Tokura; H Yagi; K Nishimura; F Furukawa; M Takigawa
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.